These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 605725)

  • 1. Non diffusible toxic polypeptides in uraemic sera: a new group of uraemic toxins.
    Gróf J; Menyhárt J
    Acta Chir Acad Sci Hung; 1977; 18(3):283-7. PubMed ID: 605725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive factors in uraemic sera are composed of both dialysable and non-dialysable components.
    Kamata K; Okubo M; Sada M
    Clin Exp Immunol; 1983 Oct; 54(1):277-81. PubMed ID: 6616971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genesis of the uraemic syndrome: role of uraemic toxins.
    Hörl WH
    Wien Klin Wochenschr; 1998 Aug; 110(15):511-20. PubMed ID: 9782569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amino acid composition of peptides with molecular weight between 500 and 1500 daltons isolated from uremic and normal sera].
    Montagna G; Buzio C; Del Monte G; Manari A; Migone L
    Minerva Nefrol; 1980; 27(2):383-6. PubMed ID: 7219861
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular weight distribution, diffusibility and comparability of middle molecular fractions prepared from normal and uremic sera by different fractionation procedures.
    Gróf J; Menyhárt J
    Nephron; 1982; 30(1):60-7. PubMed ID: 7088233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis.
    Vanholder R; De Smet R; Jacobs V; Van Landschoot N; Waterloos MA; Vogeleere P; Ringoir S
    Nephrol Dial Transplant; 1994; 9(9):1271-8. PubMed ID: 7816288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
    Tiula E
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum polypeptides in peptic ulcer patients].
    Malov IuS; Tupikova ZA
    Ter Arkh; 1986; 58(2):17-20. PubMed ID: 3704933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIP and DIP: a new view of uraemic toxicity.
    Haag-Weber M; Mai B; Cohen G; Hörl WH
    Nephrol Dial Transplant; 1994; 9(4):346-7. PubMed ID: 8084443
    [No Abstract]   [Full Text] [Related]  

  • 13. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the faction.
    Klein A; Sarnecka-Keller M; Hanicki Z
    Clin Chim Acta; 1978 Nov; 90(1):7-11. PubMed ID: 719891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro.
    Jörstad S; Kvernes S
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):221-6. PubMed ID: 362814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glucose utilization in rat diaphragm by peptides of uraemic serum isolated by high-voltage electrophoresis.
    Dzúrik R; Adam J; Grega B
    Int Urol Nephrol; 1972; 4(3):297-301. PubMed ID: 4669397
    [No Abstract]   [Full Text] [Related]  

  • 16. Osmotic concentration of polypeptides from hemofiltrate of uremic patients.
    Ehrlich K; Holland F; Turnham T; Klein E
    Clin Nephrol; 1980 Jul; 14(1):31-5. PubMed ID: 7408253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma neurotoxin concentration in uraemic polyneuropathic patients.
    Man NK; Cueille G; Zingraff J; Drueke T; Jungers P; Sausse A; Boudet J; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1978; 15():164-70. PubMed ID: 216989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion exchange chromatographic, gel filtration and isotachophoretic analysis of normal and uraemic sera.
    Menyhárt J; Gróf J
    Acta Chir Acad Sci Hung; 1981; 22(1-2):47-60. PubMed ID: 7345835
    [No Abstract]   [Full Text] [Related]  

  • 19. Uraemia and adrenocortical function in Nigerian subjects.
    Ogunlesi AO; Akanji AO; Kadiri S; Osotimehin B
    Afr J Med Med Sci; 1990 Mar; 19(1):43-8. PubMed ID: 2109519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Error in recovery rate of aminoglycosides from uraemic sera.
    Stessman J; Michel J; Sacks T
    Chemotherapy; 1977; 23(3):142-8. PubMed ID: 851502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.